NEWTOWN, PA — Helius Medical Technologies, Inc., a pioneering neurotech firm, has recently launched an open-label study aimed at improving the lives of chronic stroke survivors. The study is part of the company’s stroke registrational program and focuses on the impact of cranial-nerve non-invasive neuromodulation (CN-NINM), delivered through PoNS Therapy®, on gait and dynamic balance.
The initiative comes on the heels of promising early trial results and real-world evidence from Canada, where PoNS Therapy® is already authorized for stroke treatment. The goal now is to bring this innovative approach to the U.S., potentially transforming the lives of over five million stroke patients affected by walking and balance disability.
The first site to enroll patients in the study is Brooks Rehabilitation, under the direction of Dr. Mark Bowden, a renowned expert in neurorehabilitation. Brooks Rehabilitation is no stranger to Helius’ work, as it is already participating in the company’s ongoing investigator-initiated, placebo-controlled study in stroke, led by Dr. Steven Kautz at the Medical University of South Carolina.
Dr. Antonella Favit-Van Pelt, Helius’ Chief Medical Officer, spoke of the significance of the study: “The open-label study will serve as an integral part of our stroke registrational program by bringing the PoNS clinical experience to additional sites in the U.S.”
Dr. Bowden echoed her enthusiasm, saying, “Brooks is very excited to be on the cutting edge in testing this promising technology. We are hopeful that PoNS Therapy can have a meaningful therapeutic effect on chronic stroke survivors.”
The open-label study represents a key step towards authorization of PoNS Therapy® in the U.S., offering hope to millions of stroke survivors. As Helius continues its push towards innovation, industry watchers will be keenly observing the outcomes of this groundbreaking study and the potential new horizons it may open in stroke rehabilitation.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.